II-VI Incorporated, a leader in laser technology and subsystems, has announced the introduction of its multi-wavelength laser module product line for life sciences.
The rapidly growing number of photonics-based instruments for life sciences, including fluorescence-based imaging systems, flow cytometers, and DNA sequencers, is driving the demand for multi-functional laser product platforms that can be easily reconfigured while still delivering very high performance. II-VI’s multi-wavelength laser modules can be configured with up to four lasers in many visible wavelength combinations and maintain outstanding near-field intensity uniformity of greater than 80% with output power ranging from 1 mW to 5 W, making them well-suited for a broad range of life sciences instruments.
Dr Sanjai Parthasarathi, Chief Marketing Officer said that the widespread reliance on PCR testing for COVID-19 showcases how instruments for life sciences have increasingly come to rely on high-quality light sources and optics, and they believe that this trend will continue to accelerate. Leveraging their core competency in thermoelectrics and photonics, along with their ISO-certified biomedical assembly facilities, their highly experienced new product introduction teams provide the customers in life sciences with world-class turnkey support from product concept to volume production.
II-VI’s multi-wavelength laser modules can be custom-configured with up to four wavelengths in the visible – blue (405/450/465/488 nm), green (520/532 nm), or red (640/660 nm). They are fully integrated with an ARM microcontroller to enable software configuration and remote monitoring. Compact and customizable, II-VI’s modules deliver the highest-quality performance and reliability. They can be easily integrated into instrumentation platforms for a wide range of life sciences applications.
II-VI’s broad portfolio of products for instrumentation in life sciences includes visible-wavelength lasers, precision optics, filters, assemblies, and thermoelectric modules. System providers can expand assembly manufacturing at II-VI’s facilities in Dallas, Texas; Fuzhou, China; and Ho Chi Minh City, Vietnam, which are certified to ISO 13485 for biomedical assemblies.
II-VI will showcase its broad product line of optics and lasers for life sciences at the 2021 SPIE BiOS Digital Marketplace, March 6-11, 2021.